Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis

S Shuo Yang (Department of Polymer Science & Engineering, State Key Laboratory of Analytical Chemistry for Life Science, MOE Key Laboratory of High Performance Polymer Materials and Technology, School of Chemistry) Y Yibing Hou X Xiaohui Wang S Shuo Kang Z Zhenhua Pan

Article Details

Journal PLoS ONE
Volume / Issue Vol. 21, Issue 7
Published July 14, 2026
Pages e0353864
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science

ISSN: 1932-6203 Open Access Health Sciences

Authors (5)

S

Shuo Yang

Department of Polymer Science & Engineering, State Key Laboratory of Analytical Chemistry for Life Science, MOE Key Laboratory of High Performance Polymer Materials and Technology, School of Chemistry

Y

Yibing Hou

X

Xiaohui Wang

S

Shuo Kang

Z

Zhenhua Pan